Notice of Effectiveness · EFFECT
Pluri Inc.
PLURNASDAQEQUITYCurrent
Notice of Effectiveness
Structured filing — EFFECT
primary_doc.xml
Notice details
- Submission type
- EFFECT
- Act
- 33
Effectiveness
- Effective date
- 2026-10-15
- Effective time (as filed)
- 16:00:00
- Form
- S-1
Registrant 1
- Registrant
- Pluri Inc.
- Registrant CIK
- 0001158780
- File number
- 333-299324
Company context
We are a biotechnology company leveraging our proprietary three-dimensional, or 3D, cell expansion platform, which is supported by an in-house, industrial-scale cell manufacturing facility and operates in accordance with Good Manufacturing Practice standards on a self-declared basis. Our platform is designed to enable scalable, cost-efficient and reproducible expansion of human, plant and animal cells and supports cell-based products, services, therapeutics and related technologies across two primary application areas: (i) Human Health and Longevity, and (ii) Foodtech and Bio-Farming.